Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

TrimTabs and BarclayHedge: Hedge funds take in $2.3bn in March, total assets $1.8tln (est.) in Q1

Wednesday, May 09, 2012
Opalesque Industry Update — BarclayHedge and TrimTabs Investment Research reported today that the hedge fund industry added $2.3 billion (0.1% of assets) in March 2012, down from a $6.8 billion inflow in February and only the fourth monthly inflow since July 2011. Based on data from 3,034 funds, the March TrimTabs/BarclayHedge Hedge Fund Flow Report estimated that industry assets stood at $1.8 trillion in March, up 2.2% from $1.7 trillion in February.

In the first quarter of 2012, ended March 31, TrimTabs and Barclay Hedge reported industry outflows amounted to $3.2 billion. In the same period, the industry managed a mere 5.61% gain, while the S&P 500 surged 12%. “Hedge fund industry returns continued to lag popular financial industry benchmarks,” said Charles Biderman, founder and CEO of TrimTabs.

Asset growth in the hedge fund industry has been in a perpetual slide since July 2007, in contrast to its impressive year-over-year growth in assets after 2000, according to TrimTabs and BarclayHedge. “Though asset growth rebounded in the summer of 2009, it petered out in May of 2010 and has been sliding ever since, even as equity market asset prices remained resilient and surged strongly in Q1 2012,” said Sol Waksman, founder and president of BarclayHedge.

Two hedge fund investment strategies are attracting more investors, according to the TrimTabs and BarclayHedge report. “Macro and Fixed Income hedge funds are the only strategies that have seen sizable inflows as a percentage of assets over the past three years,” said Leon Mirochnik, an analyst at TrimTabs. “Hedge fund investors see these strategies as offering the best defense against unpredictable geopolitical issues and global expansionary monetary policies,” he said.

Hedge funds based in Japan have been very popular in the past year, generating an inflow of 15.4% of assets despite losing 4.3%. “Apparently investors were betting they could capitalize on an appreciating yen over the past 12 months, but the yen lost 0.9% against the U.S. dollar in that time period,” Mirochnik said.

Meanwhile, the April 2012 TrimTabs/BarclayHedge Survey of Hedge Fund Managers found that nearly half the hedge fund managers surveyed believe that sometime this year the S&P 500 will trade below 1257, where the index stood at the end of 2011. A plurality, 31.3%, of the 68 managers surveyed in the third week of April think the S&P 500 will not fall below 1257 this year.

The managers surveyed did not show a strong conviction about the S&P 500 performance this month. Opinions were 33.8% bullish, 35.3% neutral, and 30.9% bearish. Bearishness inched upward to a five-month high, the markedly neutral tone of March faded in April, and a small rise in bullishness this month still remained far below the levels of December 2011 through February 2012, the survey found.

While sentiment on the U.S. Dollar Index saw only minor changes, hedge fund managers’ outlook on 10-Year Treasuries saw dramatic shifts in April: Bearishness shrank to 18.5% from 48.4% in March, neutral sentiment jumped to 63.1% from 38.7%, and bullishness rose to 18.5% from 12.9%, the survey found.

(press release)

The TrimTabs/BarclayHedge database tracks hedge fund flows on a monthly basis. The Survey of Hedge Fund Managers appears monthly in the TrimTabs/BarclayHedge Hedge Fund Flow Report, which provides detailed analysis of hedge fund flows, assets, and returns alongside topical studies. For further information, please visit http://www.barclayhedge.com/products/trimtabs-hedge-fund-flow-report.html

TrimTabs Investment Research is the only independent research service that publishes detailed daily coverage of U.S. stock market liquidity—including mutual fund flows and exchange-traded fund flows—as well as weekly withheld income and employment tax collections. Founded by Charles Biderman, TrimTabs has provided institutional investors with trading strategies since 1990. www.TrimTabs.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for